SVB Wealth LLC Has $765,000 Stake in HCA Healthcare, Inc. (NYSE:HCA)

SVB Wealth LLC decreased its holdings in HCA Healthcare, Inc. (NYSE:HCA) by 27.9% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 2,825 shares of the company’s stock after selling 1,092 shares during the quarter. SVB Wealth LLC’s holdings in HCA Healthcare were worth $765,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also bought and sold shares of the business. Stone House Investment Management LLC acquired a new position in shares of HCA Healthcare in the 3rd quarter valued at approximately $25,000. BluePath Capital Management LLC acquired a new position in shares of HCA Healthcare in the 3rd quarter valued at approximately $27,000. Centerpoint Advisors LLC acquired a new position in shares of HCA Healthcare in the 4th quarter valued at approximately $27,000. Bruce G. Allen Investments LLC acquired a new position in shares of HCA Healthcare in the 4th quarter valued at approximately $28,000. Finally, Annis Gardner Whiting Capital Advisors LLC acquired a new position in shares of HCA Healthcare in the 3rd quarter valued at approximately $30,000. Institutional investors and hedge funds own 62.73% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities research analysts recently issued reports on HCA shares. Truist Financial lifted their price target on shares of HCA Healthcare from $320.00 to $345.00 and gave the company a “buy” rating in a report on Wednesday, January 31st. Barclays started coverage on shares of HCA Healthcare in a report on Wednesday, March 6th. They set an “overweight” rating and a $356.00 price target on the stock. StockNews.com lowered shares of HCA Healthcare from a “strong-buy” rating to a “buy” rating in a report on Thursday, February 15th. Royal Bank of Canada boosted their target price on shares of HCA Healthcare from $308.00 to $322.00 and gave the stock an “outperform” rating in a report on Wednesday, January 31st. Finally, Cantor Fitzgerald reissued an “overweight” rating and set a $335.00 target price on shares of HCA Healthcare in a report on Wednesday, April 10th. Four investment analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company. Based on data from MarketBeat.com, HCA Healthcare currently has a consensus rating of “Moderate Buy” and a consensus target price of $314.05.

HCA Healthcare Stock Up 2.7 %

HCA Healthcare stock opened at $305.11 on Friday. The company has a quick ratio of 1.02, a current ratio of 1.18 and a debt-to-equity ratio of 35.07. HCA Healthcare, Inc. has a 12-month low of $215.96 and a 12-month high of $335.83. The firm’s fifty day moving average is $324.88 and its 200 day moving average is $291.93. The company has a market capitalization of $80.70 billion, a PE ratio of 16.08, a PEG ratio of 1.43 and a beta of 1.65.

HCA Healthcare (NYSE:HCA) last released its earnings results on Tuesday, January 30th. The company reported $5.90 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $5.05 by $0.85. HCA Healthcare had a net margin of 8.07% and a return on equity of 996.30%. The company had revenue of $17.30 billion for the quarter, compared to the consensus estimate of $16.51 billion. During the same quarter in the previous year, the company earned $4.64 EPS. HCA Healthcare’s quarterly revenue was up 11.7% compared to the same quarter last year. As a group, sell-side analysts predict that HCA Healthcare, Inc. will post 20.58 EPS for the current fiscal year.

HCA Healthcare Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, March 29th. Shareholders of record on Friday, March 15th were issued a dividend of $0.66 per share. This is an increase from HCA Healthcare’s previous quarterly dividend of $0.60. The ex-dividend date of this dividend was Thursday, March 14th. This represents a $2.64 annualized dividend and a yield of 0.87%. HCA Healthcare’s dividend payout ratio is presently 13.91%.

HCA Healthcare declared that its board has authorized a stock buyback plan on Tuesday, January 30th that authorizes the company to buyback $6.00 billion in shares. This buyback authorization authorizes the company to reacquire up to 7.4% of its stock through open market purchases. Stock buyback plans are typically an indication that the company’s board believes its shares are undervalued.

Insiders Place Their Bets

In other HCA Healthcare news, SVP Kathryn A. Torres sold 3,861 shares of the company’s stock in a transaction on Wednesday, January 31st. The shares were sold at an average price of $307.00, for a total transaction of $1,185,327.00. Following the transaction, the senior vice president now owns 15,899 shares in the company, valued at $4,880,993. The transaction was disclosed in a filing with the SEC, which is accessible through this link. In other news, EVP Michael S. Cuffe sold 3,200 shares of the company’s stock in a transaction on Wednesday, January 31st. The shares were sold at an average price of $306.79, for a total value of $981,728.00. Following the completion of the sale, the executive vice president now owns 24,929 shares in the company, valued at approximately $7,647,967.91. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, SVP Kathryn A. Torres sold 3,861 shares of the company’s stock in a transaction on Wednesday, January 31st. The stock was sold at an average price of $307.00, for a total transaction of $1,185,327.00. Following the completion of the sale, the senior vice president now owns 15,899 shares of the company’s stock, valued at approximately $4,880,993. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 14,840 shares of company stock worth $4,588,869. Insiders own 1.60% of the company’s stock.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.